Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 46 AL 60

Mathematical models on Alzheimer's disease and its treatment: A review

Maji M, Khajanchi S.

Phys Life Rev. 2025 Mar;52:207-244. doi: 10.1016/j.plrev.2025.01.004. Epub 2025 Jan 10.

Multi-Targeting Phytochemicals for Alzheimer's Disease

Bhattacharya RS, Singh R, Panghal A, Thakur A, Singh L, Verma RK, Singh C, Goyal M, Kumar J.

Phytother Res. 2025 Mar;39(3):1453-1483. doi: 10.1002/ptr.8435. Epub 2025 Jan 15.

Epigenetics in Neurodegenerative Diseases

van Zundert B, Montecino M.

Subcell Biochem. 2025;108:73-109. doi: 10.1007/978-3-031-75980-2_3.

Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype

Ateya NH, Al-Taie SF, Jasim SA, Uthirapathy S, Chaudhary K, Rani P, Kundlas M, Naidu KS, Amer NA, Ahmed JK.

Cell Biochem Biophys. 2025 Jun;83(2):1537-1553. doi: 10.1007/s12013-025-01670-0. Epub 2025 Jan 18.

Drug repurposing using artificial intelligence, molecular docking, and hybrid approaches: A comprehensive review in general diseases vs Alzheimer's disease

Zulhafiz NA, Teoh TC, Chin AV, Chang SW.

Comput Methods Programs Biomed. 2025 Apr;261:108604. doi: 10.1016/j.cmpb.2025.108604. Epub 2025 Jan 13.

Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease-A Review

Moradi F, Mokhtari T.

J Biochem Mol Toxicol. 2025 Feb;39(2):e70071. doi: 10.1002/jbt.70071.

Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer's Diseases

Chen D, Sun Y.

J Integr Neurosci. 2025 Jan 20;24(1):23090. doi: 10.31083/JIN23090.

Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives

Kim BH, Kim S, Nam Y, Park YH, Shin SM, Moon M.

Transl Neurodegener. 2025 Jan 27;14(1):6. doi: 10.1186/s40035-025-00465-w.

Oligodendrocytes in Alzheimer's disease pathophysiology

Kedia S, Simons M.

Nat Neurosci. 2025 Mar;28(3):446-456. doi: 10.1038/s41593-025-01873-x. Epub 2025 Jan 29.

Natural products against tau hyperphosphorylation-induced aggregates: Potential therapies for Alzheimer's disease

Basurto-Islas G, Diaz MC, Ocampo LMZ, Martínez-Herrera M, López-Camacho PY.

Arch Pharm (Weinheim). 2025 Jan;358(1):e2400721. doi: 10.1002/ardp.202400721.

Alzheimer's Disease Diagnosis and Management in the Age of Amyloid Monoclonal Antibodies

Hales CM.

Med Clin North Am. 2025 Mar;109(2):463-483. doi: 10.1016/j.mcna.2024.10.003. Epub 2024 Nov 19.

Long Non-Coding RNAs: Crucial Regulators in Alzheimer's Disease Pathogenesis and Prospects for Precision Medicine

Yang C, Li Y, Chen C, Sun Z, Liu E, Wei N, Liu X, Shu J, Zhao N, Sun M.

Mol Neurobiol. 2025 Jun;62(6):7525-7541. doi: 10.1007/s12035-025-04729-4. Epub 2025 Feb 5.

Circadian rhythm, microglia-mediated neuroinflammation, and Alzheimer's disease

Geng F, Zhao N, Ren Q.

Neurosci Biobehav Rev. 2025 Mar;170:106044. doi: 10.1016/j.neubiorev.2025.106044. Epub 2025 Feb 4.

Advancements in autophagy perturbations in Alzheimer's disease: Molecular aspects and therapeutics

Dhapola R, Kumari S, Sharma P, Vellingiri B, HariKrishnaReddy D.

Brain Res. 2025 Mar 15;1851:149494. doi: 10.1016/j.brainres.2025.149494. Epub 2025 Feb 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias